oncology
1,857 projects
breast cancer168leukemia137skin cancer106prostate cancer99colorectal cancer78lung cancer67pancreatic cancer42liver cancer37cervical cancer10bladder cancer10head and neck cancer7
HEIndividual fellowship2025–2027Spain
DEXTER · Development of EXtracellular-based artificial bio-nanoparticles: a novel Targeted vector with high potential in cancer ThERapy
HEIndividual fellowship2025–2027Spain
CARLY · Development and characterization of a novel CAR T-cell therapy for NHL
2 partners
HEIndividual fellowship2025–2027Sweden
IN-FACT · INitiation FActor 3 as target in Cancer Therapy
2 partners · 2 countries
HEIndividual fellowship2025–2027Belgium
noCOLDmore · Reprogramming eNdOthelial cells in immune-COLD tuMORs
2 partners · 2 countries
HEIndividual fellowship2025–2027Belgium
DETECTIVE · DEmystifying Targets in Endothelial Cells for anti-Tumor Immunity improVEments
HEIndividual fellowship2025–2026Austria
PROSPER · Promoting RObust Systems biology on Patients and Experimental models with obesity-driven liveR cancer
HEStaff exchange2024–2028Netherlands
GRASSHOPPER · The GRASSHOPPER network: Jumping forward from preclinical development of pediatric cancer drugs to clinical implementation
18 partners · 16 countries
HEIndividual fellowship2024–2026Belgium
KetoFAPIs · Next generation ketoamide inhibitors of fibroblast activation protein (FAP) to revolutionize radionuclide therapy in cancer.
HEStaff exchange2024–2028Poland
PurHumanDrome · Disrupting purine de novo biosynthesis to fight cancer - from molecules to cells to in vivo studies.
5 partners · 5 countries
HEDoctoral network2024–2028Netherlands
Mac4Me · Macrophage Targets for Metastatic Treatment
26 partners · 13 countries
HEDoctoral network2024–2028Germany
UPLIFT · UPright radiotherapy: Learning, Innovation, Fellowship and Training
23 partners · 10 countries
HEDoctoral network2024–2028Denmark
STRIM · Scientific Training for Post-Translational Modification Detection in Cancer Screening
13 partners · 6 countries
HEDoctoral network2024–2028Netherlands
MIRACLE · Integrated multi-angle research and training network to eradicate leukemia minimal residual disease
22 partners · 8 countries
HEIndividual fellowship2024–2026Netherlands
SupraCODE · Spatial control of antigen-encoded supramolecular copolymers for robust T-cell activation against cancer
HEIndividual fellowship2024–2027Germany
PCPNIHyp · Exploring perineural invasion (PNI) mechanisms in Pancreatic Cancer using hyperpolarized 13C NMR
HEIndividual fellowship2024–2026Germany
EVO-PDAC · Evolutionary dynamics of pancreatic cancer at single-cell and spatial levels
HEIndividual fellowship2024–2026Germany
ExoDiagAI · Empowering Personalized Therapeutics: Advancing 3D-Nano DLD Arrays and Raman Micro-Biochips for Precision Isolation, Segmentation, and Molecular Profiling of Exosomal Trop2 Biomarkers in TNBC
2 partners · 2 countries
HEIndividual fellowship2024–2026Croatia
TRIPOLES · Using first-principle modeling to study multipolar mitotic spindles in cancerous cells
HEIndividual fellowship2024–2026Cyprus
REINFORCE · TumoR microEnvIronment Normalization FOR enhanCed photodynamic thErapy
3 partners
HEIndividual fellowship2024–2027Sweden
Hi-NEAT · Hi-NEAT (Hierarchical Nanoengineered Assemblies of Titania) sensor
HEIndividual fellowship2024–2026Italy
MyoTumour · A novel role for skeletal muscle in tumour growth and proliferation
2 partners
HEIndividual fellowship2024–2026Belgium
ModulEndoA3 · Identification of cellular regulators and pharmacological inhibitors of endophilin-A3 to modulate its endocytic functions
2 partners · 2 countries
HEIndividual fellowship2024–2026Italy
CRINOVA · CRISPR/Cas-based innovative electrochemical multiplexed immunosensor for specific detection of ovarian carcinoma biomarkers in urine
2 partners · 2 countries
HEIndividual fellowship2024–2026Spain